[New nonsteroidal antiinflammatory drugs in rheumatoid arthritis].
Cyclooxygenase functions Fundamental aspects of coxibs Efficacy of coxibs in rheumatoid arthritis Tolerance to coxibs Conclusion
Berenbaum
Francis
F
Service de Rhumatologie, Hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France. francis.berenbaum@sat.ap-hop-paris.fr
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068579:Celecoxib; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D013450:Sulfones; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib